NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of NurExone Biologic Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. NurExone Biologic Inc market cap is $56.2M.
What is the 52-week high for NurExone Biologic Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NurExone Biologic Inc 52 week high is $0.80 as of October 18, 2025.
What is the 52-week low for NurExone Biologic Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NurExone Biologic Inc 52 week low is $0.3776 as of October 18, 2025.
What is NurExone Biologic Inc stock price today?
NurExone Biologic Inc stock price today is $0.6003.
What was NurExone Biologic Inc stock price yesterday?
NurExone Biologic Inc stock price yesterday was $0.6236.
What is the PE ratio of NurExone Biologic Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. NurExone Biologic Inc’s P/E ratio is -6.64.
What is the Price-to-Book ratio of NurExone Biologic Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. NurExone Biologic Inc P/B ratio is 31.3478.
What is the 50-day moving average of NurExone Biologic Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NurExone Biologic Inc 50-day moving average is $0.6384.
